Treatment with the investigational injection therapy itolizumab significantly reduced urine protein levels, a marker of kidney dysfunction, in people with…
Articles by Marisa Wexler, MS
An arm of China’s National Medical Products Administration has given Kezar Life Sciences the green light to open sites…
The first participant has been treated in a Phase 1 clinical trial testing the CAR T-cell therapy CC-97540 (BMS-986353) in…
The antimalarial agent hydroxychloroquine doesn’t appear to lower the risk of preeclampsia during pregnancy in women with lupus, a…
Scientists have created small molecules that can block the activity of SLC15A4, an inflammatory protein — long considered undruggable —…
Men with systemic lupus erythematosus (SLE) are more likely to experience kidney failure and heart attacks, while women with…
The U.S. Food and Drug Administration (FDA) has cleared Century Therapeutics to start a Phase 1 clinical trial that…
The U.S. Food and Drug Administration (FDA) has given Gracell Biotechnologies the green light to start a Phase 1/2…
Depression and anxiety are more likely in people with systemic lupus erythematosus (SLE) who also are at a greater…
The U.S. Food and Drug Administration (FDA) has granted fast track designation to IMPT-514, a CAR T-cell therapy being developed…